Form 4: NBIX CSO Gifts 2,441 Shares of Common Stock

Neurocrine Biosciences Chief Scientific Officer Jude Onyia reported a gift of 2,441 common stock shares effective June 5, 2026.

Summary

• Jude Onyia, Chief Scientific Officer of Neurocrine Biosciences Inc. (NBIX), reported a disposition of common stock.
• The transaction involved a gift/charitable contribution of 2,441 shares of NBIX common stock.
• The transaction was effective on June 5, 2026.
• No monetary value was received for the gifted shares, with a reported price of $0.
• Following this transaction, Onyia beneficially owns 23,405 shares of NBIX common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a standard disclosure of an insider's personal stock disposition via gift, with no direct operational or financial implications for the company.

Industry Context

StockSavvy.ai notes that insider gift transactions, while not directly impacting company operations, reflect individual executive decisions regarding personal holdings. Such filings are standard disclosures for officers and directors and are common across various industries.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a personal transaction by an executive and does not affect the company's operational or financial performance.

Key Dates

Recommendation

This Form 4 reports a personal gift of shares by a Chief Scientific Officer and does not provide information that would alter the fundamental investment thesis for Neurocrine Biosciences. It is a routine disclosure of an insider's personal holdings change.

Keywords

Neurocrine Biosciences, NBIX, Jude Onyia, Chief Scientific Officer, Form 4, Insider Transaction, Stock Gift, Beneficial Ownership